• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与灵长类红细胞补体受体结合的免疫复合物是如何转移至受体吞噬细胞的?

How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?

作者信息

Nardin A, Lindorfer M A, Taylor R P

机构信息

Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville 22908, USA.

出版信息

Mol Immunol. 1999 Sep-Oct;36(13-14):827-35. doi: 10.1016/s0161-5890(99)00103-0.

DOI:10.1016/s0161-5890(99)00103-0
PMID:10698336
Abstract

Immune complexes (IC) bound to the primate erythrocyte (E) complement receptor (CR1) are cleared from the circulation of primates and localized to phagocytic cells in the liver and spleen without E destruction. IC can be bound to E CRI either via C3b opsonization or with cross-linked mAb complexes (heteropolymers, HP) which contain a mAb specific for CRI and a mAb specific for an antigen. The long-term goal of our work is to apply the HP system to the treatment of human diseases associated with blood-borne pathogens. This review discusses the mechanism by which the E-bound IC are transferred to acceptor cells. Our studies in animal models as well as our in vitro investigations indicate that IC transfer is rapid (usually >90% in 10 min) and does not lead to lysis or phagocytosis of the E. Experiments with specific inhibitors and the use of IC prepared with Fab' fragments suggest that transfer depends mainly upon recognition by Fc receptors on the acceptor cell. Moreover, we find that IC release from the E is associated with a concerted loss of CR1, and is followed by uptake and internalization of the IC by the acceptor cell. We suggest that recognition and binding of the E-bound IC substrates by Fc receptors allows close contact between the E and acceptor cells, which in turn facilitates proteolysis of E CR1, presumably by a macrophage-associated protease. After proteolysis, the released IC are internalized by the macrophages.

摘要

与灵长类红细胞(E)补体受体(CR1)结合的免疫复合物(IC)可从灵长类动物的循环系统中清除,并定位于肝脏和脾脏中的吞噬细胞,而不会导致E被破坏。IC可以通过C3b调理作用或与交联的单克隆抗体复合物(异聚物,HP)结合到E CRI上,其中HP包含对CRI特异的单克隆抗体和对抗原特异的单克隆抗体。我们工作的长期目标是将HP系统应用于治疗与血源性病原体相关的人类疾病。这篇综述讨论了与E结合的IC转移至受体细胞的机制。我们在动物模型中的研究以及体外研究表明,IC转移迅速(通常在10分钟内>90%),且不会导致E的裂解或吞噬。使用特异性抑制剂的实验以及用Fab'片段制备的IC的实验表明,转移主要取决于受体细胞上Fc受体的识别。此外,我们发现IC从E上释放与CR1的协同丢失有关,随后IC被受体细胞摄取并内化。我们认为,Fc受体对与E结合的IC底物的识别和结合使E与受体细胞紧密接触,这反过来又促进了E CR1的蛋白水解,推测是由巨噬细胞相关蛋白酶介导的。蛋白水解后,释放的IC被巨噬细胞内化。

相似文献

1
How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?与灵长类红细胞补体受体结合的免疫复合物是如何转移至受体吞噬细胞的?
Mol Immunol. 1999 Sep-Oct;36(13-14):827-35. doi: 10.1016/s0161-5890(99)00103-0.
2
Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.与红细胞上非补体受体1(CR1)位点结合的C3b调理免疫复合物的处理:吞噬作用、转移以及与CR1的关联。
J Immunol. 2005 Mar 1;174(5):3059-66. doi: 10.4049/jimmunol.174.5.3059.
3
Transfer of immune complexes from erythrocyte CR1 to mouse macrophages.免疫复合物从红细胞补体受体1转移至小鼠巨噬细胞。
J Immunol. 2000 Feb 15;164(4):1977-85. doi: 10.4049/jimmunol.164.4.1977.
4
Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1 mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model.在恒河猴模型中,通过抗CR1单克隆抗体与灵长类红细胞补体受体(CR1)结合的免疫复合物在协同反应中随着CR1的丧失而同时被清除。
Clin Immunol Immunopathol. 1997 Jan;82(1):49-59. doi: 10.1006/clin.1996.4286.
5
A prototype pathogen bound ex vivo to human erythrocyte complement receptor 1 via bispecific monoclonal antibody complexes is cleared to the liver in a mouse model.在小鼠模型中,一种通过双特异性单克隆抗体复合物在体外与人红细胞补体受体1结合的病原体原型被清除至肝脏。
Eur J Immunol. 1999 May;29(5):1581-6. doi: 10.1002/(SICI)1521-4141(199905)29:05<1581::AID-IMMU1581>3.0.CO;2-V.
6
Heteropolymer-mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications.通过红细胞补体受体1介导的杂聚物清除免疫复合物:机制与应用
Immunol Rev. 2001 Oct;183:10-24. doi: 10.1034/j.1600-065x.2001.1830102.x.
7
Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.抗双链DNA抗体的清除:天然免疫复合物清除机制
Arthritis Rheum. 2000 Oct;43(10):2265-75. doi: 10.1002/1529-0131(200010)43:10<2265::AID-ANR14>3.0.CO;2-J.
8
Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse model.与人类红细胞补体受体结合的免疫复合物的协同清除:一种异源小鼠模型的建立
J Immunol Methods. 2002 Dec 15;270(2):183-97. doi: 10.1016/s0022-1759(02)00296-x.
9
Visualization of the transfer reaction: tracking immune complexes from erythrocyte complement receptor 1 to macrophages.转移反应的可视化:追踪免疫复合物从红细胞补体受体1到巨噬细胞的过程。
Clin Immunol. 2002 Oct;105(1):36-47. doi: 10.1006/clim.2002.5266.
10
Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.模型免疫复合物与红细胞CR1的结合促进U937细胞对免疫复合物的摄取。
J Immunol. 1989 Jun 15;142(12):4366-71.

引用本文的文献

1
CD47 regulates antigen modulation and red blood cell clearance following an incompatible transfusion.CD47在不相容输血后调节抗原调节和红细胞清除。
Front Immunol. 2025 Apr 4;16:1548548. doi: 10.3389/fimmu.2025.1548548. eCollection 2025.
2
The Molecular Mechanisms of Complement Receptor 1-It Is Complicated.补体受体 1 的分子机制——错综复杂。
Biomolecules. 2023 Oct 13;13(10):1522. doi: 10.3390/biom13101522.
3
Beyond Binding: The Outcomes of Antibody-Dependent Complement Activation in Human Malaria.超越结合:抗体依赖性补体激活在人类疟疾中的结局。
Front Immunol. 2021 Jun 8;12:683404. doi: 10.3389/fimmu.2021.683404. eCollection 2021.
4
The good, the bad, and the opportunities of the complement system in neurodegenerative disease.补体系统在神经退行性疾病中的好坏与机遇。
J Neuroinflammation. 2020 Nov 25;17(1):354. doi: 10.1186/s12974-020-02024-8.
5
Complement-Mediated Events in Alzheimer's Disease: Mechanisms and Potential Therapeutic Targets.阿尔茨海默病中的补体介导事件:机制和潜在治疗靶点。
J Immunol. 2020 Jan 15;204(2):306-315. doi: 10.4049/jimmunol.1901068.
6
Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude.红细胞“搭便车”可将纳米载体递送至目标器官,效率提高数个数量级。
Nat Commun. 2018 Jul 11;9(1):2684. doi: 10.1038/s41467-018-05079-7.
7
Incomplete Antibodies May Reduce ABO Cross-Match Incompatibility: A Pilot Study.不完全抗体可能减少ABO血型交叉配血不相容性:一项初步研究。
Turk J Haematol. 2018 Mar 1;35(1):54-60. doi: 10.4274/tjh.2016.0504. Epub 2017 May 23.
8
Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier.与红细胞结合的药物递送:一种古老血管内载体的新途径。
Ther Deliv. 2015 Jul;6(7):795-826. doi: 10.4155/tde.15.34.
9
Malaria inhibits surface expression of complement receptor 1 in monocytes/macrophages, causing decreased immune complex internalization.疟疾抑制单核细胞/巨噬细胞表面补体受体 1 的表达,导致免疫复合物内化减少。
J Immunol. 2013 Apr 1;190(7):3363-72. doi: 10.4049/jimmunol.1103812. Epub 2013 Feb 25.
10
Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence.补体受体 1 在小鼠红细胞上的表达介导免疫黏附清除肺炎链球菌。
Infect Immun. 2010 Jul;78(7):3129-35. doi: 10.1128/IAI.01263-09. Epub 2010 May 3.